Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-10T15:04:33.681Z Has data issue: false hasContentIssue false
  • English
  • Français

Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia

Published online by Cambridge University Press:  04 March 2010

Daniel W. O'Connor ,
Joanne Griffith  and
Kate McSweeney
Daniel W. O'Connor*
Affiliation:
Aged Mental Health Research Unit, School of Psychology and Psychiatry, Monash University, Melbourne, Australia
Joanne Griffith
Affiliation:
Aged Mental Health Research Unit, School of Psychology and Psychiatry, Monash University, Melbourne, Australia
Kate McSweeney
Affiliation:
Aged Mental Health Research Unit, School of Psychology and Psychiatry, Monash University, Melbourne, Australia
*
Correspondence should be addressed to: Daniel O'Connor, Professor of Old Age Psychiatry, Kingston Centre, Warrigal Road, Cheltenham, Victoria 3192, Australia. Phone: +613 9265-1700; Fax: +613 9265-1711. Email: daniel.oconnor@med.monash.edu.au.
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: Nursing home residents are often prescribed large numbers of psychotropic medications. Previous studies suggest that antipsychotic medications are often unnecessary and can be withdrawn without ill effects. Depression, in contrast, is believed to be under-recognized and under-treated.

Method: A six-month audit was carried out of the antipsychotic, antidepressant, anxiolytic and hypnotic medications prescribed to 166 newly admitted residents of a convenience sample of seven nursing homes in Melbourne, Australia.

Results: Over the six-month period, antidepressants were started in 6% of all cases and stopped in 2% of treated cases. Antipsychotics were added in 5% of all cases and stopped in 15% of treated cases. Residents were switched from one antidepressant to another in 5% of treated cases and from one antipsychotic to another in 4%. Benzodiazepine use was relatively modest.

Conclusions: Judging from epidemiological data, treatment revisions were almost certainly insufficient to address residents’ mental health needs. We discuss ways of harnessing existing nursing and pharmacy resources to ensure better care for aged residents.

Keywords

Antipsychoticantidepressantbenzodiazepineprescribingnursing homes
Type
Research Article
Information
International Psychogeriatrics , Volume 22 , Special Issue 7: Focus on mental health issues in long-term-care homes , November 2010 , pp. 1149 - 1153
Copyright
Copyright © International Psychogeriatric Association 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Geriatrics Society and American Association for Geriatric Psychiatry (2003). Consensus statement on improving the quality of mental health care in U.S. nursing homes: management of depression and behavioural symptoms associated with dementia. Journal of the American Geriatrics Society, 51, 1287–1298.CrossRefGoogle Scholar
Ballard, C. G. et al. (2004). A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. Journal of Clinical Psychiatry, 65, 114–119.CrossRefGoogle ScholarPubMed
Banerjee, S., Shamash, K., Macdonald, A. J. D., Mann, A. H. (1996). Randomised controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home. BMJ, 1996, 1058–1061.CrossRefGoogle Scholar
Blanchard, M. R., Waterreus, A. and Mann, A. H. (1995). The effect of a primary care nurse intervention upon older people screened as depressed. International Journal of Geriatric Psychiatry, 10, 289–298.CrossRefGoogle Scholar
Brodaty, H. et al. (2001). Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors. International Journal of Geriatric Psychiatry, 16, 504–512.Google Scholar
Bronskill, S. E. et al. (2004). Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose and specialist contact. Journal of the American Geriatrics Society, 52, 749–755.Google Scholar
Bruce, M. L. et al. (2004). Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA, 291, 1081–1091.CrossRefGoogle ScholarPubMed
Carlson, W. L. and Snowden, M. (2007). Improving treatment for depression in the nursing home population: integrating the model of the depression care manager. Harvard Review of Psychiatry, 15, 128–132.CrossRefGoogle ScholarPubMed
Chow, E. S. L. et al. (2004). The prevalence of depressive symptoms among elderly Chinese private nursing home residents in Hong Kong. International Journal of Geriatric Psychiatry, 19, 734–740.Google Scholar
Cohen-Mansfield, J. et al. (1999). Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Archives of Internal Medicine 159, 1733–1740.CrossRefGoogle ScholarPubMed
Conn, D. K., Ferguson, I., Mandelman, K. and Ward, C. (1999). Psychotropic drug utilization in long-term-care facilities for the elderly in Ontario, Canada. International Psychogeriatrics, 11, 223–233.CrossRefGoogle ScholarPubMed
Draper, B. et al. (2001). Use of psychotropics in Sydney nursing homes: associations with depression, psychosis and behavioral disturbances. International Psychogeriatrics, 13, 107–120.CrossRefGoogle ScholarPubMed
Gobert, M. and D'hoore, W. (2005). Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. International Journal of Geriatric Psychiatry, 20, 712–721.CrossRefGoogle ScholarPubMed
Greve, M. and O'Connor, D. (2005). A survey of Australian and New Zealand old age psychiatrists’ preferred medications to treat behavioral and psychological symptoms of dementia. International Psychogeriatrics, 17, 165–178.CrossRefGoogle ScholarPubMed
Hosia-Randell, H. and Pitkälä, K. (2005). Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs and Aging, 22, 793–800.CrossRefGoogle ScholarPubMed
International Psychogeriatric Association (2003). Behavioral and Psychological Symptoms of Dementia. Chicago, IL: IPA.Google Scholar
Llewellyn-Jones, R. H., Baikie, K. A., Smithers, H., Cohen, J. and Snowdon, J. (1999). Multi-faceted shared care intervention for late life depression in residential care: randomized controlled trial. BMJ, 1999, 676–682.CrossRefGoogle Scholar
Lövheim, H, Sandman, P. O., Kallin, K., Karlsson, S. and Gustafson, Y. (2008). Symptoms of mental health and psychotropic drug use in geriatric care, changes between 1982 and 2000. International Journal of Geriatric Psychiatry, 23, 289–294.Google Scholar
Mann, E., Köpke, S., Haastert, B., Pitkäla, K. and Meyer, G. (2009). Psychotropic medication use among nursing home residents in Austria: a cross-national study. BMC Geriatrics. doi: 10.1186/1471-2318-9-18.Google Scholar
McSweeney, K. and O'Connor, D. W. (2008). Depression among newly admitted Australian nursing home residents. International Psychogeriatrics, 20, 724–737.CrossRefGoogle ScholarPubMed
Mulsant, B. H. et al. (2001). Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm. International Journal of Geriatric Psychiatry, 16, 585–592.Google Scholar
Nakajima, G. A. and Wenger, N. S. (2007). Quality indicators for the care of depression in vulnerable elders. Journal of the American Geriatrics Society, 55, S302–S311.CrossRefGoogle ScholarPubMed
Nijk, R. M., Zuidema, S. U. and Koopmans, R. T. C. M. (2009). Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. International Psychogeriatrics, 21, 485–493.CrossRefGoogle ScholarPubMed
Roberts, M. S. et al. (2001). Outcomes of an RCT of a clinical pharmacy intervention in 52 nursing homes. British Journal of Clinical Pharmacology, 51, 257–65.CrossRefGoogle Scholar
Ryan, J. M., Kidder, S. W., Daiello, L. A. and Tariot, P. N. (2002). Psychopharmacologic interventions in nursing homes: what do we know and where should we go? Psychiatric Services, 53, 1407–1413.CrossRefGoogle ScholarPubMed
Schmidt, I. et al. (1998). The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. Journal of the American Geriatrics Society, 46, 77–82.CrossRefGoogle ScholarPubMed
Selbæk, G., Kirkevold, Ø. and Engedal, K. (2008). The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes – a 12-month follow-up study. American Journal of Geriatric Psychiatry, 16, 528–536.CrossRefGoogle ScholarPubMed
Shrank, W. H., Polinski, J. M. and Avorn, J. (2007). Quality indicators for medication use in vulnerable elders. Journal of the American Geriatrics Society, 55, S373–S382.Google Scholar
Smalbrugge, M., Jongenelis, L., Pot, A. M., Eefsting, J. A., Ribbe, M. W. and Beekman, A. T. F. (2006). Incidence and outcome of depressive symptoms in nursing home residents in the Netherlands. American Journal of Geriatric Psychiatry, 14, 1069–1076.Google Scholar
Snowden, M., Sato, K. and Roy-Byrne, P. (2003). Assessment and treatment of nursing home residents with depression and behavioral symptoms associated with dementia: a review of the literature. Journal of the American Geriatrics Society, 51, 1305–1317.Google Scholar
Snowdon, J., Vaughan, R., Miller, R., Burgess, E. E. and Tremlett, P. (1995). Psychotropic drug use in Sydney nursing homes. Medical Journal of Australia, 163, 70–72.Google Scholar
Snowdon, J., Day, S. and Baker, W. (2006). Current use of psychotropic medication in nursing homes. International Psychogeriatrics, 18, 241–250.CrossRefGoogle ScholarPubMed
Sørensen, L., Foldspang, A., Gulmann, N. C. and Munk-Jørgensen, P. (2001). Determinants for the use of psychotropics among nursing home residents. International Journal of Geriatric Psychiatry, 16, 147–154.Google Scholar
Unützer, J. et al. (2002). Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA, 288, 2836–2845.Google Scholar